Utah Medical Products Profit Margin 2006-2018 | UTMD

Current and historical gross margin, operating margin and net profit margin for Utah Medical Products (UTMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Utah Medical Products net profit margin as of December 31, 2018 is 44.18%.
Utah Medical Products Annual Profit Margins
Utah Medical Products Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.313B $0.042B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.447B 27.76
Medtronic (MDT) Ireland $124.271B 18.17
Stryker (SYK) United States $73.087B 26.83
Boston Scientific (BSX) United States $52.902B 25.79
Baxter (BAX) United States $39.768B 25.44
Zimmer Biomet Holdings (ZBH) United States $25.701B 16.45
Smith & Nephew SNATS (SNN) United Kingdom $17.481B 0.00
Canopy Growth (CGC) Canada $15.431B 0.00
ResMed (RMD) United States $14.029B 26.60
Aurora Cannabis (ACB) Canada $10.082B 71.14
Bio-Rad Laboratories (BIO) United States $9.411B 53.70
Hill-Rom Holdings (HRC) United States $6.960B 21.53
Perrigo (PRGO) Ireland $6.690B 10.85
Insulet (PODD) United States $5.859B 1976.60
GW Pharmaceuticals (GWPH) United Kingdom $5.071B 0.00
ICU Medical (ICUI) United States $4.915B 30.60
Haemonetics (HAE) United States $4.429B 39.29
Hutchison China MediTech (HCM) China $3.856B 0.00
Agios Pharmaceuticals (AGIO) United States $3.806B 0.00
Neogen (NEOG) United States $3.332B 51.18
NuVasive (NUVA) United States $2.882B 25.14
Quidel (QDEL) United States $2.658B 23.98
Aphria (APHA) $2.606B 115.67
National Vision Holdings (EYE) United States $2.333B 45.89
HEXO (HEXO) $1.460B 0.00
Cardiovascular Systems (CSII) United States $1.372B 985.25
VAREX IMAGING (VREX) United States $1.306B 25.56
Phibro Animal Health (PAHC) United States $1.294B 18.60
AtriCure (ATRC) United States $1.108B 0.00
Lantheus Holdings (LNTH) United States $0.947B 25.58
MacroGenics (MGNX) United States $0.921B 0.00
Cerus (CERS) United States $0.868B 0.00
Omeros (OMER) United States $0.861B 0.00
PetIQ (PETQ) United States $0.815B 23.33
NanoString Technologies (NSTG) United States $0.755B 0.00
Evolus (EOLS) United States $0.725B 0.00
OraSure Technologies (OSUR) United States $0.713B 31.24
Meridian Bioscience (VIVO) United States $0.705B 21.00
Eagle Pharmaceuticals (EGRX) United States $0.680B 23.15
TG Therapeutics (TGTX) United States $0.653B 0.00
Surmodics (SRDX) United States $0.616B 89.55
LeMaitre Vascular (LMAT) United States $0.610B 29.03
Quanterix (QTRX) United States $0.550B 0.00
BioLife Solutions (BLFS) United States $0.376B 155.15
Insys Therapeutics (INSY) United States $0.358B 0.00
Rockwell Medical (RMTI) United States $0.357B 0.00
Vapotherm (VAPO) United States $0.335B 0.00
Owens & Minor (OMI) United States $0.283B 3.91
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.270B 0.00
Bovie Medical (APYX) United States $0.266B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Fonar (FONR) United States $0.143B 7.64
Surface Oncology (SURF) United States $0.142B 0.00
Zynex (ZYXI) United States $0.142B 15.17
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.098B 0.00
United-Guardian (UG) United States $0.088B 18.33
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.087B 0.00
CAS Medical Systems (CASM) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
Neurotrope (NTRP) United States $0.056B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
NeuroMetrix (NURO) United States $0.008B 15.00